• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:朱勇,王鸿,何俏军.PARP抑制剂WZ-8体内外抗肿瘤作用研究[J].中国现代应用药学,2014,31(6):682-686.
ZHU Yong,WANG Hong,HE Qiaojun.Study of the Poly(ADP-ribose) Polymerase Inhibitor WZ-8 for Cancer Therapy in Vitro and in Vivo[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(6):682-686.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2805次   下载 1633 本文二维码信息
码上扫一扫!
分享到: 微信 更多
PARP抑制剂WZ-8体内外抗肿瘤作用研究
朱勇1,2, 王鸿1, 何俏军1
1.浙江大学药学院药理毒理与生化药学研究所,杭州 310058;2.浙江省药品不良反应监测中心,杭州 310012
摘要:
目的 研究PARP抑制剂WZ-8对人源性肿瘤细胞增殖及裸鼠移植人结肠癌(HCT116)生长的抑制作用。方法 SRB染色法和裸小鼠移植瘤模型研究WZ-8在体内外抗肿瘤作用。结果 体外WZ-8对多种人肿瘤细胞增殖有明显抑制作用,其中对结肠癌细胞HCT116的半数抑制浓度IC50为(0.21±0.01)mg·mL-1。体内研究表明WZ-8(20 mg·kg-1)对小鼠移植HCT116肿瘤生长有一定抑制效果,其体内外抗肿瘤活性均高于同类化合物Iniparib。结论 WZ-8在体外对人源性肿瘤细胞增殖有明显抑制作用,在体内可抑制裸鼠移植人结肠癌细胞HCT116的生长。
关键词:  PARP抑制剂  WZ-8  Iniparib  人结肠癌细胞HCT116
DOI:
分类号:
基金项目:
Study of the Poly(ADP-ribose) Polymerase Inhibitor WZ-8 for Cancer Therapy in Vitro and in Vivo
ZHU Yong1,2, WANG Hong1, HE Qiaojun1
1.Institute of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China;2.Zhejiang Center for Adverse Drug Reaction Monitoring, Hangzhou 310012, China
Abstract:
OBJECTIVE To investigate the effect of poly(ADP-ribose) polymerase inhibitor WZ-8 on proliferation and growth of human colonic carcinoma HCT116 cells in vitro and in vivo. METHODS SRB assay and xenografted model were performed to detect proliferation inhibition effect of WZ-8 on cancer cells. RESULTS WZ-8 obviously inhibited the growth of 10 different human cancer cells in vitro. The IC50 of WZ-8 on HCT116 cells was lower than other cancer cells. WZ-8 also exhibited higher anti-tumor activity of HCT116 xenografted mice than Iniparib in vivo. CONCLUSION WZ-8 exertes a significant inhibition on proliferation and growth of HCT116 cancer cells both in vitro and in vivo.
Key words:  Poly(ADP-ribose) polymerase inhibitor  WZ-8  Iniparib  HCT116 cells
扫一扫关注本刊微信